1. Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells
- Author
-
Tongzeng Li, Yuxuan Wang, Hao Wu, Lili Dai, Shengzhang Lin, Wen Wang, Xiaojie Huang, Tong Zhang, Wei Li, and Hongfei Tong
- Subjects
Anatomy and Physiology ,lcsh:Medicine ,Apoptosis ,Immune Physiology ,Molecular Cell Biology ,Basic Cancer Research ,Interferon gamma ,STAT1 ,lcsh:Science ,STAT3 ,beta Catenin ,Multidisciplinary ,medicine.diagnostic_test ,biology ,Hep G2 Cells ,Flow Cytometry ,STAT1 Transcription Factor ,Oncology ,Interferon Type I ,Intercellular Signaling Peptides and Proteins ,Cytokines ,Medicine ,Oncology Agents ,Signal transduction ,medicine.drug ,Signal Transduction ,Research Article ,STAT3 Transcription Factor ,Carcinoma, Hepatocellular ,Enzyme-Linked Immunosorbent Assay ,Flow cytometry ,Molecular Genetics ,Interferon-gamma ,Cell Line, Tumor ,Gastrointestinal Tumors ,medicine ,In Situ Nick-End Labeling ,Genetics ,Humans ,Gene Regulation ,Biology ,Cell Proliferation ,Cell growth ,lcsh:R ,Cancers and Neoplasms ,Hepatocellular Carcinoma ,DKK1 ,Cancer research ,biology.protein ,lcsh:Q ,Interferons - Abstract
Background/Objective IFNs are a group of cytokines that possess potent antiviral and antitumor activities, while β-catenin pathway is a proliferative pathway involved in carcinogenesis. Interaction between these two pathways has not been well elaborated in hepatocellular carcinoma (HCC). Methods HCC cell lines, HepG2 and Huh7, were used in this study. β-catenin protein levels and corresponding signaling activities were observed by flow cytometry and luciferase assay, respectively. Cell proliferation was quantified by counting viable cells under microscope, and apoptosis by TUNEL assay. DKK1 and GSK3β levels were determined by flow cytometry. Secreted DKK1 was tested by ELISA. FLUD, S3I and aDKK1 were used to inhibit STAT1, STAT3 and DKK1 activities, respectively. Results Our findings show that all three types of IFNs, IFNα, IFNγ and IFNλ, are capable of inhibiting β-catenin signaling activity in HepG2 and Huh7 cells, where IFNγ was the strongest (p
- Published
- 2012